REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
Development Bisphosphonates are a major class of drugs used to treat osteoporosis (OP) and other diseases characterized by increased bone resorption. The literature contains indisputable evidence for the efficacy of alendronate in the registered oral dose of 70 mg once weekly in the treatment of pos...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2010-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|